ArticleMedicine2017

Erratum: Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.